nebracetam has been researched along with hemicholinium 3 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furukawa, T; Kushiku, K; Ohjimi, H; Yamada, H | 1 |
| Furukawa, T; Kohno, Y; Kushiku, K; Kuwahara, T; Ohjimi, H; Yamada, H | 1 |
2 other study(ies) available for nebracetam and hemicholinium 3
| Article | Year |
|---|---|
Presynaptic facilitation by the new nootropic drug nebracetam, of ganglionic muscarinic transmission in the dog cardiac sympathetic ganglion.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Angiotensin II; Animals; Dimethylphenylpiperazinium Iodide; Dogs; Electric Stimulation; Female; Ganglia, Sympathetic; Heart; Heart Rate; Hemicholinium 3; Male; Parasympathetic Nervous System; Parasympathomimetics; Psychotropic Drugs; Pyrrolidinones; Synaptic Transmission | 1991 |
Increase of acetylcholine release by nebracetam in dog cardiac sympathetic ganglion.
Topics: Acetylcholine; Animals; Bethanechol; Bethanechol Compounds; Choline; Choline O-Acetyltransferase; Dogs; Drug Interactions; Heart; Hemicholinium 3; In Vitro Techniques; Molecular Structure; Psychotropic Drugs; Pyrrolidinones; Stellate Ganglion; Synaptic Transmission | 1994 |